Maria Sklodowska-Curie National Research Institute of Oncology
- Country
- 🇵🇱Poland
- Ownership
- Private
- Established
- 1951-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.pib-nio.pl/
Preoperative Immunotherapy Combined With Stereotactic Radiation Therapy Boost in the Treatment of HER2-negative Breast Cancer
- Conditions
- Interventions
- First Posted Date
- 2024-06-25
- Last Posted Date
- 2024-06-25
- Target Recruit Count
- 78
- Registration Number
- NCT06472583
- Locations
- 🇵🇱
Maria Sklodowska-Curie National Research Institute of Oncology , Gliwice Branch, Gliwice, Poland
Stereotactic Radiosurgery in Patients With Head and Neck Region Tumours
- Conditions
- Interventions
- First Posted Date
- 2024-06-25
- Last Posted Date
- 2024-06-25
- Target Recruit Count
- 80
- Registration Number
- NCT06472570
- Locations
- 🇵🇱
1st Radiation and Clinical Oncology Department, Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice Branch,, Gliwice, Gliwicw, Poland
177Lu-PSMA as a Systemic Adjuvant Treatment in Patients With High and Very High Risk Prostate Cancer
- Conditions
- Interventions
- First Posted Date
- 2024-06-10
- Last Posted Date
- 2024-06-10
- Target Recruit Count
- 200
- Registration Number
- NCT06449781
Stereotactic Re-irradiation of Local Recurrences of Prostate Cancer After Radiotherapy
- Conditions
- Interventions
- First Posted Date
- 2024-01-11
- Last Posted Date
- 2024-06-26
- Target Recruit Count
- 60
- Registration Number
- NCT06201078
- Locations
- 🇵🇱
Maria Sklodowska Memorial Research Institute of Oncology, Gliwice, Poland
The Evaluation of the Effectiveness, Safety and Tolerability of Treatment, Using a PSMA-Lu177, in Patients With ACC- an Open, Non-commercial Clinical Trial
- Conditions
- Interventions
- First Posted Date
- 2024-01-10
- Last Posted Date
- 2024-01-10
- Target Recruit Count
- 32
- Registration Number
- NCT06199453
- Locations
- 🇵🇱
Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland
Pembrolizumab in Combination with Eftilagimod Alpha and Radiotherapy in Neoadjuvant Treatment of Patients with Soft Tissue Sarcoma - EFTISARC-NEO Trial
- Conditions
- Interventions
- First Posted Date
- 2023-11-13
- Last Posted Date
- 2024-11-19
- Target Recruit Count
- 40
- Registration Number
- NCT06128863
- Locations
- 🇵🇱
Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
Induction Treatment in SCC of the Head and Neck Region - Concomitant Chemotherapy and Low-dose Radiotherapy
- Conditions
- Interventions
- First Posted Date
- 2023-08-15
- Last Posted Date
- 2023-08-15
- Target Recruit Count
- 40
- Registration Number
- NCT05992610
- Locations
- 🇵🇱
The Maria Sklodowska-Curie National Research Institute of Oncology, Branch in Gliwice, Gliwice, Silesia, Poland
Stereotactic Management of Arrhythmia - Radiosurgery Treatment and Evaluation of Response in Ventricular Tachycardia
- Conditions
- Interventions
- First Posted Date
- 2023-06-22
- Last Posted Date
- 2023-10-19
- Target Recruit Count
- 20
- Registration Number
- NCT05913375
- Locations
- 🇵🇱
Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland
🇵🇱Professor Leszek Giec Upper Silesian Medical Center of the Medical University of Silesia, Katowice, Poland
The Effect of Methods of Self-regulation of Mental State on Pain Perception in the Postoperative Period in Colon Cancer Patients
- Conditions
- Interventions
- First Posted Date
- 2023-02-01
- Last Posted Date
- 2023-02-01
- Target Recruit Count
- 100
- Registration Number
- NCT05708872
- Locations
- 🇵🇱
Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland
Pembrolizumab in the Treatment of Advanced, Progressive Adrenocortical Carcinoma.
- Conditions
- Interventions
- First Posted Date
- 2022-10-03
- Last Posted Date
- 2023-03-07
- Target Recruit Count
- 24
- Registration Number
- NCT05563467
- Locations
- 🇵🇱
Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, ÅšlÄ…skie, Poland